Antidepressant Drugs Flashcards
1
Q
citalopram
A
- SSRI
- selectively inhibit pre-synaptic reuptake of 5-HT
- LITTLE EFFECT on histamine, muscarinic, or adrenergic receptors
- risk of SUICIDE, SEROTONIN SYNDROME, CNS depression, decreased libido, weight gain, ACUTE withdrawal rxns
2
Q
escitalopram
A
- SSRI
- selectively inhibit pre-synaptic reuptake of 5-HT
- LITTLE EFFECT on histamine, muscarinic, adrenergic receptors, or CYP450
- risk of SUICIDE, SEROTONIN SYNDROME, CNS depression, decreased libido, weight gain, ACUTE withdrawal rxns
3
Q
fluoxetine
A
- SSRI
- selectively inhibit pre-synaptic reuptake of 5-HT
- INHIBITS CYP450
- LITTLE EFFECT on histamine, muscarinic, or adrenergic receptors
- risk of SUICIDE, SEROTONIN SYNDROME, CNS depression, decreased libido, weight gain, ACUTE withdrawal rxns
4
Q
paroxetine
A
- SSRI
- selectively inhibit pre-synaptic reuptake of 5-HT
- LITTLE EFFECT on histamine, muscarinic, or adrenergic receptors
- risk of SUICIDE, SEROTONIN SYNDROME, CNS depression, decreased libido, weight gain, ACUTE withdrawal rxns
5
Q
sertraline
A
- SSRI
- selectively inhibit pre-synaptic reuptake of 5-HT
- LITTLE EFFECT on histamine, muscarinic, or adrenergic receptors
- risk of SUICIDE, SEROTONIN SYNDROME, CNS depression, decreased libido, weight gain, ACUTE withdrawal rxns
6
Q
vilazodone
A
- SSRI
- selectively inhibit pre-synaptic reuptake of 5-HT
- ALSO a partial agonist at 5-HT1a receptor
- LITTLE EFFECT on histamine, muscarinic, or adrenergic receptors
- risk of SUICIDE, SEROTONIN SYNDROME, CNS depression, decreased libido, weight gain, ACUTE withdrawal rxns
7
Q
vortioxetine
A
- SSRI
- selectively inhibit pre-synaptic reuptake of 5-HT\
- ALSO a partial agonist at 5-HT1b, and a FULL agonist at 5-HT1a and 5-HT1d3,7 receptors
- LITTLE EFFECT on histamine, muscarinic, adrenergic receptors, or CYP450
- risk of SUICIDE, SEROTONIN SYNDROME, CNS depression, decreased libido, weight gain, ACUTE withdrawal rxns
8
Q
amitryptyline
A
- TCA and SNRI
- 3° amine (inhibit NE<5-HT)
- selectively inhibit pre-synaptic reuptake of 5-HT and norepinephrine
- risk of coma, cardiotoxicity, convulsions
9
Q
clomipramine
A
- TCA and SNRI
- 3° amine (inhibit NE<5-HT)
- selectively inhibit pre-synaptic reuptake of 5-HT and norepinephrine
- risk of coma, cardiotoxicity, convulsions
10
Q
doxepin
A
- TCA and SNRI
- 3° amine (inhibit NE/5-HT equally)
- selectively inhibit pre-synaptic reuptake of 5-HT and norepinephrine
- risk of coma, cardiotoxicity, convulsions
11
Q
imipramine
A
- TCA and SNRI
- 3° amine (inhibit NE/5-HT equally)
- selectively inhibit pre-synaptic reuptake of 5-HT and norepinephrine
- used for ENURESIS
- risk of coma, cardiotoxicity, convulsions
12
Q
amoxapine
A
- TCA and SNRI
- 2° amine (inhibit NE>5-HT)
- selectively inhibit pre-synaptic reuptake of 5-HT and norepinephrine
- risk of coma, cardiotoxicity, convulsions
13
Q
desipramine
A
- TCA and SNRI
- 2° amine (inhibit NE>5-HT)
- selectively inhibit pre-synaptic reuptake of 5-HT and norepinephrine
- risk of coma, cardiotoxicity, convulsions
14
Q
nortriptyline
A
- TCA and SNRI
- 2° amine (inhibit NE>5-HT)
- selectively inhibit pre-synaptic reuptake of 5-HT and norepinephrine
- risk of coma, cardiotoxicity, convulsions
15
Q
desvenlafaxine
A
- SNRI
- selectively inhibit pre-synaptic reuptake of 5-HT and norepinephrine
- risk of SUICIDE, SEROTONIN SYNDROME, CNS depression, decreased libido, weight gain, ACUTE withdrawal rxns
16
Q
duloxetine
A
- SNRI
- selectively inhibit pre-synaptic reuptake of 5-HT and norepinephrine
- used for Diabetic Peripheral Neuropathy, Fibromyalgia, Chronic musculoskeletal pain, and stress incontinence
- risk of SUICIDE, SEROTONIN SYNDROME, CNS depression, decreased libido, weight gain, ACUTE withdrawal rxns
17
Q
venlafaxine
A
- SNRI
- selectively inhibit pre-synaptic reuptake of 5-HT and norepinephrine
- risk of SUICIDE, SEROTONIN SYNDROME, CNS depression, decreased libido, weight gain, ACUTE withdrawal rxns
18
Q
levomilnacipran
A
- SNRI
- selectively inhibit pre-synaptic reuptake of 5-HT and norepinephrine
- risk of SUICIDE, SEROTONIN SYNDROME, CNS depression, decreased libido, weight gain, ACUTE withdrawal rxns
19
Q
trazodone
A
- SARA
- acts like SSRI and also blocks post synaptic α1 receptors, 5-HT2 receptors, and H1 receptors
- causes sedation and priapism
- risk of orthostatic hypotension
20
Q
nefazodone
A
- SARA
- acts like SSRI and also blocks post synaptic α1 receptors, 5-HT2 receptors, and H1 receptors
- causes sedation
21
Q
mirtazapine
A
- SARA
- acts like SSRI and also blocks presynaptic α2 receptors, 5-HT2/3 receptors, and H1 receptors
- risk of weight gain
22
Q
buproprion
A
- NDRI
- selectively inhibits reuptake of NE and DA on presynaptic neurons
- enhances release of NE and DA via VMAT2 effects
- used for NICOTINE WITHDRAWAL and as a stimulating drug
- risk of agitation, weight loss, and SEIZURE
23
Q
isocarboxazid
A
- MAOI
- increases the amount of NE, DA, and 5-HT in vesicles and the amount released
- risk of serotonin syndrome when taken with other antidepressants or tyramine containing foods
24
Q
phenelzine
A
- MAOI
- increases the amount of NE, DA, and 5-HT in vesicles and the amount released
- risk of serotonin syndrome when taken with other antidepressants or tyramine containing foods
25
Q
selegiline
A
- MAOI
- MAO-B selective, given as transdermal patch
- increases the amount of NE, DA, and 5-HT in vesicles and the amount released
- risk of serotonin syndrome when taken with other antidepressants or tyramine containing foods
26
Q
tranylcypromine
A
- MAOI
- increases the amount of NE, DA, and 5-HT in vesicles and the amount released
- risk of serotonin syndrome when taken with other antidepressants or tyramine containing foods
27
Q
esketamine
A
- NMDA receptor antagonist
- used in treatment resistant depression w/ ongoing antidepressant therapy
- intranasal administration
- need to watch pt for BP change, and dissociation, sedation
28
Q
brexanolone
A
- GABAa receptor positive allosteric modulator
- used in post-partum depression
- 60-hr IV administration, lasts up to 30 days
- need to watch pt for somnolence, and loss of consciousness
29
Q
carbamazepine
A
- mood stabilizer
- anti-seizure drug
- used in acute and maintenance of mixed episodes in bipolar I
- CYP450 inducer
30
Q
lamotrigine
A
- mood stabilizer
- anti-seizure drug
- used in maintenance of bipolar I and II
31
Q
divalproex/valproic acid
A
- mood stabilizer
- anti-seizure drug
- used for bipolar I
32
Q
lithium
A
- mood stabilizer
- maintenance of mania, and reduced suicide risk
- inhibits DA transmission which helps manic episodes
- downregulates NMDA receptor
- promotes GABAergic transmission
- risk of nephrogenic diabetes insipidus, drug interactions with diuretics, ACEIs, NSAIDs
- narrow therapeutic window